AstraZeneca PLC March 2025 SEC Filing: Upcoming AGM Details & Key Insights

Here are the key insights and information extracted from the financial report section:

1. Form Type and Filing Details:

• The document is a Form 6-K, a report of a foreign issuer filed with the SEC.
• The filing pertains to the month of March 2025, specifically regarding AstraZeneca PLC.

2. Company Information:

• Name: AstraZeneca PLC
• Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
• SEC Commission File Number: 001-11960.

3. Annual General Meeting (AGM) Details:

• Date and Time: The AGM is scheduled for April 11, 2025, at 14:30 BST.
• Format: The meeting will be digitally-enabled.
• Notice Distribution: The Notice of the AGM and Shareholders' Circular were published and dispatched to shareholders on March 7, 2025.

4. Access to Documents:

• The Notice and proxy form are available for inspection at the National Storage Mechanism and on the company’s website (astrazeneca.com/noticeofmeeting2025).

5. Business to be Conducted at the AGM:

• Review of the Company’s Accounts, Directors' and Auditor's Reports, and Strategic Report for the year ended December 31, 2024.
• Confirmation of 2024 interim dividends.
• Re-appointment of PricewaterhouseCoopers LLP as Auditor.
• Authorization of Directors regarding Auditor remuneration.
• Election or re-election of Directors.
• Approval of the Chair of the Remuneration Committee’s annual statement and Annual Report on Remuneration.
• Authorization of limited political donations.
• Authorization to allot shares and disapply pre-emption rights in specific circumstances.
• Authorization for the Company to purchase its own shares.
• Proposal to reduce the notice period for general meetings.

6. Voting Rights:

• Only holders of ordinary shares registered by 18:30 BST on April 9, 2025, will have the right to attend or vote at the AGM.
• The Record Date for Euroclear Sweden system participants is April 2, 2025, and for holders of American Depositary Receipts, it is February 25, 2025.

7. Contact Information:

• The document is signed by Adrian Kemp, Company Secretary.

This summary provides an overview of the upcoming AGM, the key agenda items, and the necessary details for shareholders regarding participation and voting rights.